How current assay approval policies are leading to unintended imprecision medicine
Research output: Contribution to journal › Comment/debate › Research › peer-review
| Original language | English |
|---|---|
| Journal | Lancet Oncology |
| Volume | 21 |
| Issue number | 11 |
| Pages (from-to) | 1399-1401 |
| Number of pages | 3 |
| ISSN | 1470-2045 |
| DOIs |
|
| Publication status | Published - Nov 2020 |
- Biomarkers, Pharmacological, Clinical Trials as Topic, Drug Approval, Humans, Immunotherapy, Insurance, Health, Neoplasms/drug therapy, Precision Medicine, Risk Factors
Research areas
ID: 259928343